Quantification of free metanephrines in human plasma by LC-MS/MS for clinical research

Significance of the topic

The free metanephrines—metanephrine, normetanephrine and 3-methoxytyramine—in human plasma are key biomarkers for diagnosing pheochromocytoma and extra-adrenal chromaffin tumors. Their low endogenous concentrations and polar properties make analytical determination challenging. Sensitive, robust and reliable quantification methods are essential in clinical research to support accurate diagnosis and treatment decisions.

Objectives and Study Overview

This work aimed to establish and validate a liquid chromatography–tandem mass spectrometry (LC-MS/MS) method for quantifying free metanephrines in human plasma. The study focused on sample preparation via protein precipitation, online solid-phase extraction, chromatographic separation and detection on a Thermo Scientific TSQ Altis triple quadrupole mass spectrometer. Performance metrics included calibration linearity, accuracy and intra-/inter-assay precision.

Methodology and Instrumentation

Sample preparation involved adding deuterated internal standards to 100 µL plasma followed by protein precipitation. After centrifugation, the supernatant was directly injected for online SPE and UHPLC separation. Chromatographic runtime was 6 minutes, using a binary gradient to resolve analytes. Detection utilized heated electrospray ionization in positive mode and selected reaction monitoring. Method validation assessed calibration range, bias and precision across three concentration levels.

Used Instrumentation

• Thermo Scientific Vanquish Flex Binary UHPLC system with biocompatible switching valve for online SPE
• RECIPE ClinMass LC-MS/MS Complete Kit for Free Metanephrines in Plasma (online analysis)
• Thermo Scientific TSQ Altis triple quadrupole mass spectrometer with heated electrospray ionization
• TraceFinder 4.1 software for data acquisition and processing

Main Results and Discussion

The method delivered linear responses over calibration ranges (normetanephrine 40–1974 ng/L, metanephrine 28–1384 ng/L, 3-methoxytyramine 18–1477 ng/L) with 1/X weighted linear interpolation. Accuracy biases for quality controls ranged from −8.6% to +4.2%, meeting ±15% criteria. Intra-assay precision (%CV) was below 10.2% and inter-assay precision below 9.1% for all analytes. Representative chromatograms and calibration curves confirmed robust separation and reproducible quantitation.

Benefits and Practical Applications of the Method

• High sensitivity and specificity support reliable clinical research data.
• Online SPE integration reduces manual handling and sample volume.
• Short runtime (6 min) increases laboratory throughput.
• Comprehensive kit simplifies preparation and enhances reproducibility.

Future Trends and Applications

Emerging trends may include further automation of sample handling, miniaturized flow paths to enhance sensitivity, and coupling with high-resolution mass spectrometry for broader metabolic profiling. Expanding multiplex assays and adapting workflows for point-of-care platforms could further support clinical decision-making.

Conclusion

The presented LC-MS/MS method offers a rapid, sensitive and precise approach for quantifying free plasma metanephrines in clinical research. Validation demonstrated acceptable linearity, accuracy and precision. The workflow integrates online SPE and a complete sample preparation kit, meeting research laboratory requirements for robust metanephrine analysis.

Reference

• Barcenas M, Calvet M. Quantification of free metanephrines in human plasma by LC-MS/MS for clinical research. Thermo Fisher Scientific Technical Note 73768, 2020.